Proud of our Sylvester Comprehensive Cancer Center Sylvester Sarcoma Team expert Emily Jonczak, MD discussing critical and underutilized predictive biomarkers in #GIST #Sarcoma The Life Raft Group LifeFest.

Thank you sooooo much to UMiami for having me as a VP to give the Dr. Van Wyhe memorial lecture. Amazing day and forever grateful. ❤️ Sylvester Comprehensive Cancer Center UMiami Health System Crystal Seldon Taswell, MD Cris Takita, MD, MBA

Incredible opportunity to join a dynamic team committed to making a lasting impact in #PancreaticCancer Sylvester Comprehensive Cancer Center in this work funded by The V Foundation and Dolphins Cancer Challenge

george demetri What an impactful life as a diagnostician, scientist and colleague continually challenging the status quo. Great educator and role model, too. I always looked forward to and undoubtedly enjoyed interacting with him professionally and personally.

Imaging-Based Disease Assessment & Management Recommendations: Impact of Multidisciplinary #Sarcoma Tumor Board Sylvester Comprehensive Cancer Center Sylvester Sarcoma Team MDPI Francesco Alessandrino, MD Ty Subhawong Emily Jonczak, MD Aditi Dhir Gina Z. D'Amato, MD. Steve Bialick, DO mdpi.com/2072-6694/16/1…

Details to follow! Hold those dates for an all-star line up in general pathology. #UMiamiPath

#JurassicPark or #CoconutGrove?

Happy DCC Registration Day! Registration opens at 12 pm EDT at ridedcc.com

A nice incidental finding - hibernoma of bone. For unclear reasons it results in a sclerotic appearance on imaging. #umiamipath Gangahar CN, et al. Intraosseous hibernoma: clinicopathologic and imaging analysis of 18 cases. Histopathology. 2023 Jul;83(1):40-48. PMID: 37099409.

Help me & Pap Corps Champions For Cancer Research raise crucial funds for #cancerresearch to benefit Sylvester Comprehensive Cancer Center at the Dolphins Cancer Challenge dolphins.donordrive.com/index.cfm?fuse…

Now online! What an honor to co-author this review with Sangeetha Venugopal MD,MS for JAMA Oncology on Contemporary Management of Acute Myeloid Leukemia! Sylvester Comprehensive Cancer Center UMiami Health System jamanetwork.com/journals/jamao…

Hear From Colleagues: Silvia Garcia is a Project Manager at Sylvester Comprehensive Cancer Center Her background in biological sciences and clinical research complements her work with EMPOWER, a program that supports female faculty at Sylvester. #SylvesterStrong #UMAlum

Dumont Syndrome= #GIST plus #Desmoid Tumor. First Description of the Clinical Activity of Avapritinib in Sporadic Mesenteric Desmoid Tumor. ⁦Gabriel Tinoco⁩ ⁦Desmoid Tumor Research Foundation⁩ ⁦The Life Raft Group⁩ pubmed.ncbi.nlm.nih.gov/39135981/

Part 1 of my interview w/⁦OncLive.com⁩ discussing my study GUIAR A Culturally Tailored Lung Cancer Screening for Hispanic Head and Neck Cancer Survivors ⁦⁦Dr. Estela Rodriguez⁩ ⁦gilberto lopes⁩ ⁦#FlorezLab⁩ ⁦CRANE Lab⁩ ⁦⁦ onclive.com/view/dr-olazag…

Amazing work Coral Olazagasti, MD!! Tune in to hear one of our bright 🌟 Sylvester Comprehensive Cancer Center!!!

Jon Trent, MD, PhD Gabriel Tinoco Desmoid Tumor Research Foundation The Life Raft Group Fascinating! While Pazo and Sora are well-tested TKIs, I've always wondered if newer TKIs (Cabo, Zanza) could work too. This might be a class effect. We now have a beta cat-specific drug in our Phase 1 portfolio at Yale, which could be a great fit for DT patients. Exciting times!

📝New publication from Gabriel Tinoco & colleagues: First Description of the Clinical Activity of Avapritinib in Sporadic Mesenteric Desmoid Tumor pubmed.ncbi.nlm.nih.gov/39135981/

Hey, watch out! Here it is our review on the management of soft tissue #sarcoma published on AnnalsSurgOncology A collaborative effort from Hopital Maisonneuve-Rosemont & Istituto Tumori Mai-Kim Gervais and I go through the approach to the main histologic types and sites.

Management of sarcoma is very sophisticated and is mandatory to regionlize it to maximize the chance of cure! rdcu.be/dRJZx CTOS TARPSWG Italian Sarcoma Group SPAGN Society of Surgical Oncology European Society of Surgical Oncology (ESSO) EORTC SICO SICO Social Sarcoma ESMO - Eur. Oncology ASCO Chirurgia dei Sarcomi INT

Expert oncologists discuss the U.S. FDA approval of nirogacestat for the treatment of desmoid tumors and explore its impact on clinical practice and the future treatment landscape. Chandrajit Raut Dr. Bui Pathologist🌼 Mark Agulnik, MD Jon Trent, MD, PhD #Oncology #MedEd onclive.com/view/nirogaces…